Discover 395 paid clinical trials in Norfolk, Virginia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 395
Featured
Multicenter Study of Lumateperone for the Treatment of Bipolar Depression in Pediatric Patients
for
Bipolar Depression
Location: 35 recruiting locations
Sponsor: Intra-Cellular Therapies, Inc.
Sex: All
Age: 10 - 17
Code: NCT06372964
Phase3, Recruiting
Active & Responsive
The Influence of Different Mood States and Emotions on the Physiologic, Metabolic, and Perceptual Responses to Feeding Before Exercise
for
Other Gastrointestinal Disorders, Cramp, Abdominal
Location: 1 recruiting location
Sponsor: Old Dominion University
Sex: All
Age: 18 - 55
Code: NCT05217589
Recruiting
Active & Responsive
Food Orders on Blood Glucose and Fuel Use At Rest
for
Glucose Metabolism Disorders, Hunger, Fat Burn
Location: 1 recruiting location
Sponsor: Old Dominion University
Sex: All
Age: 18 - 70
Code: NCT06763562
Recruiting
Active & Responsive
JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization
for
AAA, AAA - Abdominal Aortic Aneurysm
Location: 24 recruiting locations
Sponsor: Endologix
Sex: All
Age: 21+
Code: NCT05064540
Recruiting
Active & Responsive
Pediatric Post-Approval Registry
for
Obstructive Sleep Apnea
Location: 7 recruiting locations
Sponsor: Inspire Medical Systems, Inc.
Sex: All
Age: 18 - 21
Code: NCT04457154
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of TAK-360 in Adults With Idiopathic Hypersomnia
for
Idiopathic Hypersomnia
Location: 11 recruiting locations
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06812078
Phase2, Recruiting
Active & Responsive
A Study Evaluating the Effectiveness and Safety of Risdiplam Administered in Pediatric Patients With Spinal Muscular Atrophy Who Experienced a Plateau or Decline in Function After Gene Therapy
for
Muscular Atrophy, Spinal
Location: 10 recruiting locations
Sponsor: Hoffmann-La Roche
Sex: All
Age: 0 - 2
Code: NCT05861999
Recruiting
Active & Responsive
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
for
Breast Neoplasms, Brain Neoplasms, Neoplasms by Site, Neoplasms,
Location: 10 recruiting locations
Sponsor: Stemline Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05386108
Phase1, Phase2, Recruiting
Active & Responsive
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
for
Breast Neoplasms, Breast Cancer
Location: 8 recruiting locations
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06797635
Phase2, Recruiting
Active & Responsive
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer